Regional Pharmacovigilance Centre – Pharmacovigilance Programme of India (PvPI)

The Central Drugs Standard Control Organisation (CDSCO), New Delhi, under the aegis of Ministry of Health & Family Welfare, Government of India has initiated a nation-wide Pharmacovigilance Programme in July, 2010, with the All India Institute of Medical Sciences (AIIMS), New Delhi as the National Coordinating Centre (NCC) for monitoring Adverse Drug Reactions (ADRs) in the country to safe-guard Public Health.

In year 2010, 22 ADR monitoring centres (AMCs) with AIIMS, New Delhi as National Center had been set up under this Programme.

Sri Aurobindo Institute of Medical Sciences was enrolled as AMC in first phase of PvPI to monitor drug safety.

To ensure implementation of this programme in a more effective way, the National Coordinating Centre was then shifted from the All India Institute of Medical Sciences (AIIMS), New Delhi to the Indian Pharmacopoeia Commission (IPC), Ghaziabad, (U.P.) in April, 2011.

The mission of PvPI is to safeguard the health of the Indian population by ensuring that the benefit of use of medicine outweighs the risks associated with its use.

The purpose of the PvPI is to collate data, analyze it and use the inferences to recommend informed regulatory interventions, besides communicating risks to healthcare professionals and the public.

Enclosures:

•  1. Permission Letter of AMC Click Here to View
•  2. Adverse Drug Reaction Form version 1.4 (To be filled by HealthcareProfessionals) Click Here to View (Please feel free to report ADR on [email protected] )
•  3. Pharmacovigilance Committee Click Here to View

Our Team Members:

(Department of Pharmacology)

Dr. Chhaya Goyal – Coordinator

Dr. Pooja Reddy – Dy. Coordinator

Mr. Mohammad Rafi – Pharmacovigilance Associate

(PvPI Tollfree Helpline: 1800 180 3024)